We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Unlocking the potential of ctDnA-based MRD testing to improve cancer management.
- Authors
Sloane, Hillary
- Abstract
The article focuses on advancements in personalized oncology, particularly through the use of minimal residual disease (MRD) testing in solid tumor cancers. Topics include the significance of MRD testing post-surgery to detect residual cancer cells not visible on imaging, its role in monitoring for cancer recurrence over time, and the development of highly sensitive ctDNA-based MRD tests that offer early detection capabilities surpassing traditional biomarker and imaging methods.
- Subjects
TUMOR diagnosis; PUBLIC health surveillance; CANCER relapse; CANCER patient medical care; EARLY detection of cancer; DISEASE management; TUMOR markers; MAGNETIC resonance imaging; DNA; CLINICAL pathology; CANCER chemotherapy; ADJUVANT chemotherapy; CARCINOGENESIS; INDIVIDUALIZED medicine; PATIENT monitoring
- Publication
Medical Laboratory Observer (MLO), 2024, Vol 56, Issue 6, p40
- ISSN
0580-7247
- Publication type
Article